Lupus Science & Medicine®
is a global, peer-reviewed, open access lupus journal from LFA, publishing papers on all aspects of lupus and related diseases.
Impact factor: 3.7
Citescore: 5.3
All metrics >>
Publish in LSM
Lupus Science & Medicine considers submissions of a range of article types, including original research, brief communications, study protocols and meeting reports.
Information is also provided on editorial policies and open access.
This is an open access journal that levies an Article Publishing Charge (APC). Discounts and waivers are available; details are provided in the Author Information section.
All manuscripts should be submitted online.
Published articles are discoverable via PubMed, Web of Science, Scopus and Google Scholar.
Latest Articles
Co-morbidities:
Clinical features of Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuritis associated with SLE10 October 2024
Clinical trials and drug discovery:
Methyl-donor supplementation in women with systemic lupus erythematosus with different nutritional status: the protocol for a randomised, double-blind, placebo-controlled trial8 October 2024
Biomarker studies:
5-Hydroxymethylcytosine in circulating cell-free DNA as a potential diagnostic biomarker for SLE4 October 2024
Epidemiology and outcomes:
Dancing with disorder: chorea - an unusual and neglected manifestation of antiphospholipid syndrome1 October 2024
Lupus nephritis:
SARS-CoV-2 spike aggravates lupus nephritis and lung fibrosis in systemic lupus erythematosus30 September 2024
Lupus Academy 2024
Lupus Science & Medicine was delighted to be the official journal of the 13th annual meeting of the Lupus Academy 2024. The meeting took place 6-8 September in Amsterdam, The Netherlands.
The abstracts from the conference were published as a supplement to Lupus Science & Medicine.
LSM Podcasts
Featured Video
Lupus Science & Medicine
The official journal of the Lupus Foundation of America and the premier open-access journal dedicated to lupus research.
Find out moreAltmetrics
Most Read Articles
Review:
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations22 May 2024
Clinical trials and drug discovery:
Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune disease7 March 2024
Childhood lupus:
Rituximab as an effective add-on maintenance therapy for disease activities in childhood-onset systemic lupus erythematosus19 January 2024